gip 1 vs glp 1 Science Behind and Glucagon Receptor Agonists for Obesity Research | News & Announcements TrimRX | GLP-1 vs GIP:
Description
The key word in the safety data is "no increase in serious cardiovascular events." That said, the absence of evidence is not evidence of absence
The FDA and other regulatory agencies have conducted extensive reviews of safety data from clinical trials and post-marketing surveillance
2 These are sensible adaptations, as protein is important for preserving muscle mass during GLP-1 treatment
Clinical studies and our extensive patient experience at Internal Medicine and Family Practice show that the vast majority of patients experience a substantial decrease in hunger and achieve meaningful weight loss
